Biomarin Pharmaceutical Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC BMRN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

638,725

Value ($000)

37,959

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	37,959	0.0%	638,725	12/31/2025
2025 Q3	11/14/2025	58,177	0.0%	1,074,173	9/30/2025
2025 Q2	8/14/2025	72,549	0.0%	1,319,792	6/30/2025
2025 Q1	5/19/2025	75,279	0.0%	1,064,924	3/31/2025
2024 Q4	2/14/2025	69,351	0.0%	1,055,087	12/31/2024
2024 Q3	11/14/2024	61,887	0.0%	880,453	9/30/2024
2024 Q2	8/14/2024	83,404	0.0%	1,013,040	6/30/2024
2024 Q1	5/15/2024	65,051	0.0%	744,801	3/31/2024
2023 Q4	2/14/2024	71,991	0.0%	746,640	12/31/2023
2023 Q3	11/13/2023	66,921	0.0%	756,336	9/30/2023
2023 Q2	8/11/2023	83,338	0.0%	857,029	6/30/2023
2023 Q1	5/15/2023	83,338	0.0%	857,029	3/31/2023
2022 Q4	2/14/2023	104,893	0.1%	1,013,561	12/31/2022
2022 Q3	11/14/2022	108,011	0.1%	1,274,166	9/30/2022
2022 Q2	8/12/2022	129,473	0.1%	1,562,365	6/30/2022
2022 Q1	5/16/2022	119,630	0.1%	1,551,617	3/31/2022
2021 Q4	2/14/2022	100,034	0.0%	1,132,246	12/31/2021
2021 Q3	11/15/2021	84,020	0.0%	1,087,076	9/30/2021
2021 Q2	8/16/2021	170,341	0.1%	2,041,483	6/30/2021
2021 Q1	5/14/2021	168,996	0.1%	2,238,061	3/31/2021
2020 Q4	3/1/2021	215,916	0.1%	2,462,265	12/31/2020
2020 Q3	11/13/2020	153,496	0.1%	2,017,564	9/30/2020
2020 Q2	8/14/2020	144,163	0.1%	1,168,824	6/30/2020
2020 Q1	5/15/2020	110,373	0.1%	1,306,188	3/31/2020
2019 Q4	2/14/2020	113,902	0.1%	1,347,160	12/31/2019
2014 Q1	5/23/2014	75,842	0.1%	1,111,893	3/31/2014
2013 Q4	1/31/2014	59,128	0.1%	841,428	12/31/2013